Staidson(Beijing)Biopharmaceuticals Co.,Ltd. Fundamental Rankings
This page is comprehensive fundamental data for Staidson(Beijing)Biopharmaceuticals Co.,Ltd.. Fundamentals are ordered by how Staidson(Beijing)Biopharmaceuticals Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.
Cite in Wikipedia:
| Indicator | Value | n/price | Rank | Date | Historic |
|---|---|---|---|---|---|
| Selling expenses | 608,118,587 | 0.05951 | 36 | 2015-09-30 | historic |
| Other current liabilities | 195,848,102 | 0.01916 | 119 | 2015-09-30 | historic |
| Interest receivable | 7,954,805 | 7.8E-4 | 122 | 2015-09-30 | historic |
| Disposal of fixed assets and others | 2,500,420 | 2.4E-4 | 206 | 2015-09-30 | historic |
| Proceeds from sell of investment | 250,000,000 | 0.02446 | 236 | 2015-09-30 | historic |
| Operating profit | 204,742,758 | 0.02003 | 280 | 2015-09-30 | historic |
| Net income | 173,110,046 | 0.01694 | 294 | 2015-09-30 | historic |
| Total comprehensive income | 177,948,207 | 0.01741 | 304 | 2015-09-30 | historic |
| Net cash flows from investing activities | -10,029,807 | -9.8E-4 | 308 | 2015-09-30 | historic |
| Total profit | 205,173,607 | 0.02008 | 309 | 2015-09-30 | historic |
| Other current assets | 206,268,221 | 0.02018 | 335 | 2015-09-30 | historic |
| Investment income from associate and joint venture | -10,607 | 0.0 | 376 | 2015-09-30 | historic |
| Net cash and cash equivalents ending balance | 997,639,206 | 0.09762 | 378 | 2015-09-30 | historic |
| Net change in cash | 97,666,420 | 0.00956 | 429 | 2015-09-30 | historic |
| Diluted eps | 1 | 0.0 | 447 | 2015-09-30 | historic |
| Cash from other investing activities | 310,409 | 3.0E-5 | 470 | 2015-09-30 | historic |
| Notes receivable | 80,357,855 | 0.00786 | 485 | 2015-09-30 | historic |
| Deferred tax assets | 30,254,605 | 0.00296 | 509 | 2015-09-30 | historic |
| Cash paid for taxes | 90,459,990 | 0.00885 | 578 | 2015-09-30 | historic |
| Goodwill | 4,169,076 | 4.1E-4 | 581 | 2015-09-30 | historic |
| Cash paid for dividends, profits or interests | 72,036,000 | 0.00705 | 597 | 2015-09-30 | historic |
| Minority interest | 30,553,949 | 0.00299 | 756 | 2015-09-30 | historic |
| Cash inflows from operating activities | 951,790,551 | 0.09313 | 773 | 2015-09-30 | historic |
| Revenue | 895,834,247 | 0.08766 | 773 | 2015-09-30 | historic |
| Total cost of goods sold | 704,581,964 | 0.06894 | 822 | 2015-09-30 | historic |
| Long term equity investment | 1,119,192 | 1.1E-4 | 847 | 2015-09-30 | historic |
| Cash outflows from operating activities | 776,379,324 | 0.07597 | 853 | 2015-09-30 | historic |
| Capital reserve | 637,810,425 | 0.06241 | 855 | 2015-09-30 | historic |
| Intangible assets | 96,679,013 | 0.00946 | 880 | 2015-09-30 | historic |
| Net cashflow from financing activities | -72,036,000 | -0.00705 | 975 | 2015-09-30 | historic |
| Other receivables | 14,501,707 | 0.00142 | 1013 | 2015-09-30 | historic |
| Other payables | 19,979,071 | 0.00195 | 1044 | 2015-09-30 | historic |
| Fixed assets | 230,985,504 | 0.0226 | 1062 | 2015-09-30 | historic |
| Purchases of fixed assets and others | 16,264,760 | 0.00159 | 1071 | 2015-09-30 | historic |
| Non-operating loss | 67,047 | 1.0E-5 | 1088 | 2015-09-30 | historic |
| Payroll payable | 6,021,664 | 5.9E-4 | 1090 | 2015-09-30 | historic |
| Total liabilities and equity | 1,940,125,121 | 0.18985 | 1175 | 2015-09-30 | historic |
| Total liabilities | 289,280,768 | 0.02831 | 1228 | 2015-09-30 | historic |
| Total non-current assets | 382,499,324 | 0.03743 | 1236 | 2015-09-30 | historic |
| Inventories | 23,265,355 | 0.00228 | 1270 | 2015-09-30 | historic |
| Financial expenses | -15,767,825 | -0.00154 | 1286 | 2015-09-30 | historic |
| Prepayment | 2,562,763 | 2.5E-4 | 1302 | 2015-09-30 | historic |
| Accounts payable | 4,489,387 | 4.4E-4 | 1340 | 2015-09-30 | historic |